A Novel Role for FERM Domain-Containing Protein 3 in CKD
Kidney360 · 2024-12 · 5 (12) · 1799-1812
DOI: 10.34067/kid.0000000602 ↗Kurz gefasst
Fachartikel in der Zeitschrift Kidney360, online erschienen am 16.10.2024. Verfasst von Ciarán Kennedy und 33 weiteren Autor:innen. Beteiligte Einrichtung: UCD Diabetes Complications Research Centre, UCD School of Medicine, Conway Institute, University College Dublin, Dublin, Ireland. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: US Ireland R&D partnership (SFI15/US/B3130), NIDDK NIH HHS, Diabetic Complications Consortium.
Abstract (Originalsprache)
Key Points We have identified a transcriptional signature of 93 genes associated with CKD severity and progression. Protein 4.1, ezrin, radixin, moesin domain-containing protein 3 gene expression is reduced in the context of more severe kidney disease and in individuals who go on to develop progressive disease. Protein 4.1, ezrin, radixin, moesin domain-containing protein 3 interacts with proteins of the cell cytoskeleton and cell-cell junctions in proximal tubule epithelial cells.
Background
Currently, there are limited methods to link disease severity and risk of disease progression in CKD. To better understand this potential relationship, we interrogated the renal transcriptomic profile of individuals with CKD with measures of CKD severity and identified protein 4.1, ezrin, radixin, moesin-domain containing protein 3 ( FRMD3 ) as a candidate gene for follow-up study.
Methods
RNA-sequencing was used to profile the transcriptome of CKD biopsies from the North Dublin Renal BioBank, the results of which were correlated with clinical parameters. The potential function of FRMD3 was explored by interrogating the FRMD3 interactome and assessing the effect of lentiviral mediated FRMD3 knock down on human renal proximal tubule epithelial cells by assessing cell viability, metabolic activity, and structural markers.
Results
We identified a subset of 93 genes which are significantly correlated with eGFR and percentage tubulointerstitial fibrosis at time of biopsy and with CKD progression 5 years postbiopsy. These results were validated against transcriptomic data from an external cohort of 432 nephrectomy samples. One of the top-ranking genes from this subset, FRMD3, has previously been associated with the risk of developing diabetic kidney disease. Interrogating the interactome of FRMD3 in tubule epithelial cells revealed interactions with cytoskeletal components of cell-cell junctions. Knockdown of FRMD3 expression in tubule epithelial cells resulted in increased proapoptotic activity within the cells, as well as dysregulation of E-Cadherin.
Conclusions
We have identified a panel of kidney-specific transcripts correlated with severity and progression of kidney disease, and from this, we have identified a possible role for FRMD3 in tubule cell structure and health.
Autor:innen und Institutionen
- UCD Diabetes Complications Research Centre, UCD School of Medicine, Conway Institute, University College Dublin, Dublin, Ireland.
- School of Medicine, Mater Misericordiae University Hospital, University College Dublin, Dublin, Ireland.
- Tallaght University Hospital, Dublin; and Trinity Kidney Centre, School of Medicine, Trinity College Dublin, Dublin, Ireland.
- Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
- Liangzhu Laboratory, Zhejiang University, Hangzhou, China.
- Department of Nephrology, The Children's Hospital, Zhejiang University School of Medicine and National Clinical Research Center for Child Health, Hangzhou, China.
ORCID-Profile: Ciarán Kennedy, Ross Doyle, Oisin Gough, Caitriona Mcevoy, Maria Hughes, Xin Sheng, Darrell Andrews, Eugene Dillon, Daniel Crean, Katalin Susztak, Jose Florez, Per-Henrik Groop, Niina Sandholm, Matthias Kretzler, Gareth J McKay, Alexander P Maxwell, David Matallanas, Peter J Conlon, Eoin Brennan, Catherine Godson
Förderung
- US Ireland R&D partnership (SFI15/US/B3130)
- NIDDK NIH HHS
- Diabetic Complications Consortium
- Breakthrough T1D
- Molecular Medicine Ireland Clinical and Translational Scholars
- JDRF
- Irish Nephrology Society
Zitieren
APA
Kennedy, C., Doyle, R., Gough, O., Mcevoy, C., McAnallen, S., Hughes, M., Sheng, X., Crifo, B., Andrews, D., Gaffney, A., Rodriguez, J., Kennedy, S., Dillon, E., Crean, D., Zhang, W., Yi, Z., Nair, V., Susztak, K., Hirschhorn, J., …, & Genie Consortium (2024). A Novel Role for FERM Domain-Containing Protein 3 in CKD. Kidney360, 5(12), 1799-1812. https://doi.org/10.34067/kid.0000000602
Vancouver
Kennedy C, Doyle R, Gough O, Mcevoy C, McAnallen S, Hughes M, et al. A Novel Role for FERM Domain-Containing Protein 3 in CKD. Kidney360. 2024;5(12):1799-1812. doi:10.34067/kid.0000000602
BibTeX
@article{Kennedy2024,
author = {Kennedy, Ciarán and Doyle, Ross and Gough, Oisin and Mcevoy, Caitriona and McAnallen, Susan and Hughes, Maria and Sheng, Xin and Crifo, Bianca and Andrews, Darrell and Gaffney, Andrew and Rodriguez, Javier and Kennedy, Susan and Dillon, Eugene and Crean, Daniel and Zhang, Weijia and Yi, Zhengzi and Nair, Viji and Susztak, Katalin and Hirschhorn, Joel and Florez, Jose and Groop, Per-Henrik and Sandholm, Niina and Kretzler, Matthias and McKay, Gareth J and McKnight, Amy Jayne and Maxwell, Alexander P and Matallanas, David and Dorman, Anthony and Martin, Finian and Conlon, Peter J and Sadlier, Denise M and Brennan, Eoin and Godson, Catherine and Genie Consortium, Genie Consortium},
title = {A Novel Role for FERM Domain-Containing Protein 3 in CKD},
journal = {Kidney360},
year = {2024},
volume = {5},
number = {12},
pages = {1799--1812},
doi = {10.34067/kid.0000000602}
}
EUVIMED